YS 49 inhibits Ang II-stimulated proliferation of VSMCs via induction of HO-1.

AT2R agonist C21 is a small-molecule ATR receptor (AT2R) agonist.

Tranilast is an antiallergic agent.

Azilsartan medoxomil is an orally administered angiotensin II receptor type 1 antagonist with IC50 of 0.62 nM, which used in the treatment of adults with essential hypertension.

Olmesartan Medoxomil is a synthetic imidazole-derived angiotensin II receptor antagonist, acting as a prodrug with an antihypertensive property.

Fimasartan is an improved non-peptide angiotensin II receptor blocker used for the treatment of hypertension and heart failure, which enables higher potency and longer duration than losartan.

Eprosartan Mesylate is a reversible and competitive angiotensin II receptor inhibitor.

Losartan D4 is deuterium labeled Losartan, which is an angiotensin II receptor antagonist.

Candesartan is a benzimidazole-derived and competitive AT1 inhibitor with IC50 value of 0.26 nM.